UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by ORG Wealth Partners LLC

ORG Wealth Partners LLC cut its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 31.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 530 shares of the healthcare conglomerate’s stock after selling 246 shares during the period. ORG Wealth Partners LLC’s holdings in UnitedHealth Group were worth $268,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. State Street Corp increased its position in UnitedHealth Group by 1.3% during the third quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock worth $26,626,387,000 after buying an additional 563,554 shares in the last quarter. Geode Capital Management LLC lifted its stake in shares of UnitedHealth Group by 1.6% during the third quarter. Geode Capital Management LLC now owns 19,636,704 shares of the healthcare conglomerate’s stock valued at $11,440,133,000 after buying an additional 318,039 shares during the period. Franklin Resources Inc. raised its position in UnitedHealth Group by 2.5% in the third quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate’s stock valued at $4,884,019,000 after purchasing an additional 193,800 shares during the period. International Assets Investment Management LLC grew its stake in shares of UnitedHealth Group by 78,814.4% in the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock valued at $3,096,896,000 after buying an additional 5,290,025 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its position in UnitedHealth Group by 30.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after acquiring an additional 880,183 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

Shares of NYSE UNH traded up $1.26 during mid-day trading on Friday, reaching $525.78. The company had a trading volume of 2,364,694 shares, compared to its average volume of 3,663,190. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The stock has a market cap of $483.87 billion, a PE ratio of 34.25, a P/E/G ratio of 1.53 and a beta of 0.62. The company has a 50-day moving average price of $556.20 and a two-hundred day moving average price of $561.20.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same quarter in the prior year, the firm earned $6.56 EPS. The firm’s quarterly revenue was up 9.2% on a year-over-year basis. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.60%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

Analysts Set New Price Targets

A number of equities analysts have weighed in on UNH shares. Barclays upped their price objective on shares of UnitedHealth Group from $603.00 to $655.00 and gave the company an “overweight” rating in a research report on Wednesday, November 27th. Morgan Stanley reduced their price target on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 16th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Monday, December 9th. Oppenheimer boosted their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. Two equities research analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Buy” and an average target price of $626.79.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.